Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies
Authors
Keywords
-
Journal
ADDICTION BIOLOGY
Volume 27, Issue 6, Pages -
Publisher
Wiley
Online
2022-09-01
DOI
10.1111/adb.13229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The serotonin 2A receptor agonist TCB‐2 attenuates heavy alcohol drinking and alcohol‐induced midbrain inhibitory plasticity
- (2022) Blake A. Kimmey et al. ADDICTION BIOLOGY
- Dynorphin/Kappa Opioid Receptor Activity Within the Extended Amygdala Contributes to Stress-Enhanced Alcohol Drinking in Mice
- (2022) Harold L. Haun et al. BIOLOGICAL PSYCHIATRY
- Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
- (2022) Anne K Schlag et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: a systematic review
- (2021) Bruno Romeo et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Registered Clinical Studies Investigating Psychedelic Drugs for Psychiatric Disorders
- (2021) Ashley N. Siegel et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
- (2021) Matthew J. Page et al. International Journal of Surgery
- Serotonergic regulation of the dopaminergic system: Implications for reward-related functions
- (2021) Emmanuelle Courtiol et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives
- (2021) David J. Cox et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross‐sectional survey
- (2021) Daniel Perkins et al. DRUG AND ALCOHOL REVIEW
- Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice
- (2021) Carolina Aparecida Faria Almeida et al. BEHAVIOURAL BRAIN RESEARCH
- Lisdexamfetamine and binge-eating disorder: A systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder
- (2021) Elizabeth Schneider et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The potential role of stimulants in treating eating disorders
- (2021) Aaron Keshen et al. INTERNATIONAL JOURNAL OF EATING DISORDERS
- Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism
- (2021) Marcus W. Meinhardt et al. Science Advances
- Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies
- (2020) Kristoffer A. A. Andersen et al. ACTA PSYCHIATRICA SCANDINAVICA
- Cessation and reduction in alcohol consumption and misuse after psychedelic use
- (2019) Albert Garcia-Romeu et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Examination of Recreational and Spiritual Peyote Use Among American Indian Youth
- (2019) Mark A. Prince et al. Journal of Studies on Alcohol and Drugs
- Effects of the hallucinogenic beverage ayahuasca on voluntary ethanol intake by rats and on cFos expression in brain areas relevant to drug addiction
- (2019) Luciana Marangni Nolli et al. ALCOHOL
- 5-HT2Areceptor activation normalizes stress-induced dysregulation of GABAergic signaling in the ventral tegmental area
- (2019) Blake A. Kimmey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
- (2018) Matthew W. Johnson et al. NEUROPHARMACOLOGY
- Ventral Tegmental Area GABA Neurons Are Resistant to GABA(A) Receptor-Mediated Inhibition During Ethanol Withdrawal
- (2018) Ashley C. Nelson et al. Frontiers in Neuroscience
- Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
- (2018) Michael P. Bogenschutz et al. Frontiers in Pharmacology
- The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions
- (2018) Elizabeth M. Nielson et al. Frontiers in Pharmacology
- Ayahuasca and Its DMT- and β-carbolines – Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment
- (2018) Elisangela G. Cata-Preta et al. Frontiers in Pharmacology
- Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca
- (2018) Paulo Cesar Ribeiro Barbosa et al. Frontiers in Psychiatry
- LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J Mice
- (2018) Kenneth Alper et al. Frontiers in Pharmacology
- A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents
- (2017) Hector Vargas-Perez et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Psychiatry & the psychedelic drugs. Past, present & future
- (2017) James J.H. Rucker et al. NEUROPHARMACOLOGY
- Psychedelic Drugs in Biomedicine
- (2017) Evan J. Kyzar et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Nalmefene is effective at reducing alcohol seeking, treating alcohol-cocaine interactions and reducing alcohol-induced histone deacetylases gene expression in blood
- (2016) Javier Calleja-Conde et al. BRITISH JOURNAL OF PHARMACOLOGY
- Psychological and neuropsychological assessment of regular hoasca users
- (2016) Paulo Cesar Ribeiro Barbosa et al. COMPREHENSIVE PSYCHIATRY
- Psilocybin for treating substance use disorders?
- (2016) Bas T.H. de Veen et al. Expert Review of Neurotherapeutics
- Stress Increases Ethanol Self-Administration via a Shift toward Excitatory GABA Signaling in the Ventral Tegmental Area
- (2016) Alexey Ostroumov et al. NEURON
- It’s time to take psilocybin seriously as a possible treatment for substance use disorders
- (2016) Michael P. Bogenschutz AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Psilocybin for treating substance use disorders?
- (2016) Bas T.H. de Veen et al. Expert Review of Neurotherapeutics
- Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
- (2015) Adam L. Halberstadt BEHAVIOURAL BRAIN RESEARCH
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- From ventral-medial to dorsal-lateral striatum: Neural correlates of reward-guided decision-making
- (2015) Amanda C. Burton et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice
- (2015) A.J. Oliveira-Lima et al. PHYSIOLOGY & BEHAVIOR
- Alcohol use disorders and current pharmacological therapies: the role of GABAA receptors
- (2014) Jing Liang et al. ACTA PHARMACOLOGICA SINICA
- VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation
- (2014) Taryn E Grieder et al. NATURE NEUROSCIENCE
- Monoamine neurocircuitry in depression and strategies for new treatments
- (2013) Michel Hamon et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students
- (2012) Robert M. Hallock et al. DRUG AND ALCOHOL DEPENDENCE
- Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases
- (2012) Cecilie L. Licht et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
- (2012) Teri S Krebs et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Prefrontal synaptic markers of cocaine addiction-like behavior in rats
- (2012) F Kasanetz et al. MOLECULAR PSYCHIATRY
- Animal models for medications development targeting alcohol abuse using selectively bred rat lines: Neurobiological and pharmacological validity
- (2012) Richard L. Bell et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Translating Glutamate: From Pathophysiology to Treatment
- (2011) D. C. Javitt et al. Science Translational Medicine
- Functional Interactions between Endogenous Cannabinoid and Opioid Systems: Focus on Alcohol, Genetics and Drug-Addicted Behaviors
- (2010) J. Lopez-Moreno et al. CURRENT DRUG TARGETS
- Dimethyltryptamine (DMT): Subjective effects and patterns of use among Australian recreational users
- (2010) Vince Cakic et al. DRUG AND ALCOHOL DEPENDENCE
- Assessment of addiction severity among ritual users of ayahuasca
- (2010) Josep Maria Fábregas et al. DRUG AND ALCOHOL DEPENDENCE
- Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction
- (2010) Khaled Moussawi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Ventral Tegmental Area BDNF Induces an Opiate-Dependent-Like Reward State in Naive Rats
- (2009) H. Vargas-Perez et al. SCIENCE
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Identification of a serotonin/glutamate receptor complex implicated in psychosis
- (2008) Javier González-Maeso et al. NATURE
- Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: Role of μ-opioid receptors
- (2008) C. Xiao et al. NEUROSCIENCE
- Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2
- (2007) José Antonio López-Moreno et al. NEUROSCIENCE LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More